Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea
|
|
- Kelley Marsh
- 5 years ago
- Views:
Transcription
1 Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea
2 Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia of adipocytes Related to many metabolic disorders Associated with increased cancer risk Adipose tissue: storage reservoir or endocrine organ Adiponectin 1/body mass index LOW adiponectin and IGF-I/IGF-IR signaling IGF-I: insulin-like growth factor IGF-IR: IGF-I receptor
3 Role of obesity/adipose tissue In breast cancer risk or tumor phenotype controversial Only by increased estrogen production? Adipocytokines(adipocyte-derived factors) may contribute to regulation of development and progression J Mammary Gland Biol Neoplasia 2013;18: Adiponectin: synthesized almost by adipose tissue, plasma conc. inversely correlated with adiposity Endocr Rev 2005;26: J Clin Endocrinol Metab 2001;86: Conc. - concentration
4 Adiponectin Anti-inflammatory activity Protective against metabolic disorders, such as insulin resistance, fatty acid oxidation and insulin sensitivity When reduced, risk factor for type II DM, CVD and several cancers J Clin Endocrinol Metab 2004;89: Clin Cancer Res 2003;9: Anti-proliferative in ERα(-), not in ERα(+) Br J Cancer 2008;98: Arch Pharm Res 2005;28: DM diabetes, CVD cardiovascular diseases
5 Obesity & Breast Carcinogenesis Serious risk factor, positively correlated with poor outcome Cancer Epidemiol Biomarkers Prev 2005;14: Obesity-greater aromatase activity- estrogen production : Not enough Estrogen-independent mechanism with insulin resistance, hyperinsulinemia, bioavailable IGF-I, dysregulation of IGF-IR pathway. J Carcinog 2013;12:19 Adipokines recruit macrophage that release proinflammatory molecules, which contribute insulin resistance and breast cancer tumorigenesis Oncologist 2010;15: Clin Cancer Res 2013;19:
6 Adiponectin Produced exclusively in white adipocytes Gene on chromosome 3q27 Plasma level(3~30 μg / ml )-Inversely correlated with BMI, lower in the obese J Mammary Gland Biol Neoplasia 2013;18: Mol Cell Endocrinol 2010;316: Mechanism of down regulation - unclear by proinflammatory cytokines(tnfα)? Nat Rev Immunol 2006;6: BMI body mass index
7 Adiponectin Receptors AdipoR1 Diabetes 2004;53: high affinity for globular adiponectin - abundantly in endothelial cells AdipoR2 Med Oncol 2011;28: Predominantly in the liver T-cadherin: non-classical receptor - mediating functional effect? - co-receptor? Biochemistry 2008;47: AdipoR adiponectin receptor
8 Adiponectin Signaling Adaptor (binding) protein APPL1 Cancer Biol Med 2012;9: Effective through AMPK, mtor, PI3K/Akt, MAPK, PPAR-α, STAT3, NF-kB Mostly through AMPK(cellular energy sensor) fatty acid oxidation, glucose uptake, gluconeogenesis Insulin-sensitizing through PPAR-α results in insulin sensitivity in vivo Diabetes 2003;52: Nat Med 2001;7:941-6.
9 Adiponectin & Breast Cancer Adiponectin obesity related cancer Endocr Rev 2012;33: Low adiponectin more aggressive breast cancer, by epidemiological studies J Clin Endocrinol Metab 2004;89: Down-regulation of adiponectin and lipid metabolism ethnic difference of cancer susceptibility BMC Genomics 2015;16:S11
10 Interaction between breast cancer and microenvironment 3 mechanisms of microenvironmental molecules (chemokines, cytokines, GF) 1. Increasing genetic instability of tumor 2. Inducing signaling via tumor-associated receptors thereby controlling gene expression 3. Exerting selective pressure on the cells Nat Rev Endocrinol. 2011;8: J Clin Invest 2011;121: GF growth factor
11 Malignant cell phenotype is regulated by autonomous signals from cancer cells and effects of surrounding stromal cells J Clin Endocrinol Metab 2007;92: Role of adipokines on breast tumorigenesis - Unclear and cell type dependency
12 In ERα(-) breast cancer cells Low adiponectin mediate anti-proliferation through regulating genes in cell cycle(p53, Bax, Bcl-2, c-myc, cyclin D1) Med Oncol 2011;28: Adipokine activate AMPK, which in turn inhibits mtor via tuberous sclerosis complex 2(TSC2), thus counteracting carcinogenesis/ stimulating p21, p53 to apoptosis Trends Pharmacol Sci 2005;26: Circ Res 2005;97:
13 In ERα(+) breast cancer cells: Low adiponectin increases proliferation at both genomic and non-genomic levels with positive regulation of cyclin D1 Clin Cancer Res 2009;15: Cell Cycle 2014;13: FASEB J 2015;29:
14 IGF-IR in Breast Cancer Ubiquitous transmembrane tyrosine kinase structurally similar to IR Regulates proliferation, survival, differentiation, transformation, development maintenance of cancer stem cells, epithelialmesenchymal transition, tumor microenvironment Growth Horm IGF Res 2012;22: Overexpressed in subtypes of breast cancer, when activated, interact with substrates such as IRS and SHC Nat Rev Cancer 2004;4: IR insulin receptor IRS insulin receptor substrates SHC Src-homology-2-containing protein SH2
15 Induces activation of Ras/raf/MAPK and PI3K/Akt signaling contribute to breast carcinogenesis J Biol Chem 1990;265: In hormone-dependent breast cancer, 1 IGF-IR and ERα are co-expressed 2 IGF-I acts with E2 proliferation 3 E2 up-regulates IGF-IR 4 E2 stimulates IRS-1 expression Mol Biol Clin Investig (2015) 22(2): Biochem Biophys Res Commun (2001) 288: E2 - estradiol
16 IGF-IR or IRS-1 increase drug and radio-resistance and favor recurrence Curr Cancer Drug Targets 2008;8: IGF-IR counteracts apoptosis in ERα(+) cells, activating IRS-1/PI3K pathway J Mammary Gland Biol Neoplasia 2000;5: IGF axis validated for developing targeted therapy Cancer Res 2012;72(1):3 12. Front Endocrinol 2014;5:224.
17 Adiponectin and IGF-IR interaction IGF/ IGF-IR: involved in metabolic cellular response to adiponectin Nat Med 2001;7: IGF-IR increases cancer growth through activation of Akt and MAPK Cancer Lett 2003;195: Crosstalk between adiponectin/adipor1 and IGF-IR in breast cancer Cell Cycle 2014;13:
18 Low conc. Adiponectin IGF-IR phosphorylation in ERα(+) breast cancer cells, concomitantly with ligandindependent activation of ER α. In MCF-7 cells, upon adiponectin Tx.: knockdown of ERα reduces IGF-IR phosphorylation, whereas sirna for IGF-IR prevents adiponectin-induced ERα transactivation Cell Cycle 2014;13: Conc concentration Tx - treatment
19 IGF-IR plays on formation of protein complex in induction of ERα (+) cell growth Adiponectin enhances coimmunoprecipitation of AdipoR1, APPL1, ERα, IGF-IR and c-src in MCF-7 cells This multiprotein complex lead to MAPK activation via c-src, which is abrogated by sirna targeting ERα or IGF-IR
20 In ERα (-) MDA-MB-231 cells: - adiponectin NOT lead to MAPK phosphorylation, but increase AMPK activation, which mediates antiproliferation FASEB J 2015;9: Biochem Biophys Res Commun 2006;345: Adiponectin enhances IRS-1 in ERα (+) breast cancer cells, amplifying IGF/IGF-IR growth signaling
21 Frontiers in Oncology 2015:5:157
22 Conclusion Adiponectin emerging crucial adipokine in breast carcinogenesis in obese women Interaction with receptors activates multiple pathways through interplay between ERα and IGF-IR This leads to 1) Increased MAPK activation, upregulation of genes involved in proliferation and inhibition of apoptosis 2) Induction of cell migration Antagonistic effects by adiponectin on IGF-IR signaling ONLY on ERα(-) breast cancer cells
Diabetes Mellitus and Breast Cancer
Masur K, Thévenod F, Zänker KS (eds): Diabetes and Cancer. Epidemiological Evidence and Molecular Links. Front Diabetes. Basel, Karger, 2008, vol 19, pp 97 113 Diabetes Mellitus and Breast Cancer Ido Wolf
More informationType 2 Diabetes and Cancer: Is there a link?
Type 2 Diabetes and Cancer: Is there a link? Sonali Thosani, MD Assistant Professor Department of Endocrine Neoplasia & Hormonal Disorders MD Anderson Cancer Center No relevant financial disclosures Objectives
More informationAdipose tissue and related gynecological cancers George Valsamakis
Adipose tissue and related gynecological cancers George Valsamakis Εndocrinologist Visiting Associate clinical Professor Warwick Medical School, UK European Scope Fellow in Obesity (IASO) Obesity and
More informationLa via del segnale PI3K/AKT/mTOR Inibitori di mtor nel carcinoma mammario
La via del segnale PI3K/AKT/mTOR Inibitori di mtor nel carcinoma mammario Alessandra Modena U.O.C. Oncologia Medica Direttore: Dott.ssa Stefania Gori Ospedale Sacro Cuore - Don Calabria 29 novembre 2016
More informationΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ
ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΘΩΜΑΣ ΠΑΠΑΔΟΠΟΥΛΟΣ, MD, PHD ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΙΑΤΡΙΚΟ ΔΙΑΒΑΛΚΑΝΙΚΟ ΚΕΝΤΡΟ Inflammation as a cause of disease has entered the popular imagination. Diet ( macronutrients )
More informationG-Protein Signaling. Introduction to intracellular signaling. Dr. SARRAY Sameh, Ph.D
G-Protein Signaling Introduction to intracellular signaling Dr. SARRAY Sameh, Ph.D Cell signaling Cells communicate via extracellular signaling molecules (Hormones, growth factors and neurotransmitters
More informationAdipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University
Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,
More informationBIOL212 Biochemistry of Disease. Metabolic Disorders - Obesity
BIOL212 Biochemistry of Disease Metabolic Disorders - Obesity Obesity Approx. 23% of adults are obese in the U.K. The number of obese children has tripled in 20 years. 10% of six year olds are obese, rising
More informationBreast Cancer Carcinogenesis: Mechanisms and Pathways in Hormone Receptor Positive Disease
Breast Cancer Carcinogenesis: Mechanisms and Pathways in Hormone Receptor Positive Disease 1 Nearly Two-Thirds of Metastatic Breast Cancers Express Hormone Receptors Breast cancer tumors are often classified
More informationGENERAL SUMMARY Corpus luteum is a transient endocrine structure formed from the ruptured ovarian follicle. Its main function is to secrete P 4, a pro
Corpus luteum is a transient endocrine structure formed from the ruptured ovarian follicle. Its main function is to secrete P 4, a pro-gestational hormone, essential for establishment and maintenance of
More informationMetabolic Syndrome. DOPE amines COGS 163
Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance
More informationConvergent and Divergent Mechanisms in Aging and Cancer
Convergent and Divergent Mechanisms in Aging and Cancer Mariana S. De Lorenzo, PhD Department of Cell Biology & Molecular Medicine delorems@umdnj.edu LEARNING OBJECTIVES 1. To identify convergent and divergent
More informationPhospho-AKT Sampler Kit
Phospho-AKT Sampler Kit E 0 5 1 0 0 3 Kits Includes Cat. Quantity Application Reactivity Source Akt (Ab-473) Antibody E021054-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit Akt (Phospho-Ser473) Antibody
More informationWhat is survivorship? Late effects of treatment. Concerns of survivorship
Choices to enhance vitality!!!and survival!!!!!!!!! (and how to make it work in the real world)! What is survivorship? Multiple definitions! Anyone living with cancer at any stage since diagnosis! Anyone
More informationAdipose Tissue Dysfunction and Diabetic Cardiovascular Disease
Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease Xin-Liang Ma, MD, PhD Thomas Jefferson University Philadelphia, PA USA CVD As The #1 Causes of Death In USA Male Female Heart Disease and
More informationIncreased risk of cancer with anti-diabetes drugs? : pros
24 th Spring Congress of Korean Diabetes Association Increased risk of cancer with anti-diabetes drugs? : pros Nan Hee Kim, MD, Ph.D. Professor Korea University Medical School Contents Diabetes and cancer
More informationHSN301 Diet and Disease Entire Note Summary
Topic 1: Metabolic Syndrome Learning Objectives: 1. Define obesity 2. Factors causing obesity 3. Obesity as a risk factor for metabolic syndrome 4. The pathogenesis of metabolic syndrome 5. Treatment of
More informationInsulin Resistance. Biol 405 Molecular Medicine
Insulin Resistance Biol 405 Molecular Medicine Insulin resistance: a subnormal biological response to insulin. Defects of either insulin secretion or insulin action can cause diabetes mellitus. Insulin-dependent
More informationKevin R. Fox, MD Rena Rowan Breast Center Abramson Cancer Center University of Pennsylvania Perelman School of MedicineR
Kevin R. Fox, MD Rena Rowan Breast Center Abramson Cancer Center University of Pennsylvania Perelman School of MedicineR Treatment of early stage, HER2 positive breast cancer Treatment of early stage,
More informationTargeting Inflammation in Breast Cancer Pathogenesis
Targeting Inflammation in Breast Cancer Pathogenesis Clifford Hudis, M.D. Chief, Breast Cancer Medicine Service Attending Physician, MSKCC Professor of Medicine, Weill Cornell Medical College August 7,
More informationMolecular Cell Biology - Problem Drill 19: Cell Signaling Pathways and Gene Expression
Molecular Cell Biology - Problem Drill 19: Cell Signaling Pathways and Gene Expression Question No. 1 of 10 1. Which statement about cell signaling is correct? Question #1 (A) Cell signaling involves receiving
More informationChapter 15: Signal transduction
Chapter 15: Signal transduction Know the terminology: Enzyme-linked receptor, G-protein linked receptor, nuclear hormone receptor, G-protein, adaptor protein, scaffolding protein, SH2 domain, MAPK, Ras,
More informationIL METABOLISMO EPATICO DEI CARBOIDRATI IN FISIOLOGIA E PATOLOGIA
UNIGASTRO Il fegato come centrale metabolica e i fattori di danno oltre ai virus epatitici IL METABOLISMO EPATICO DEI CARBOIDRATI IN FISIOLOGIA E PATOLOGIA Dr Elisabetta Bugianesi Divisione di Gastro-Epatologia
More informationMechanisms Associated with Dietary Energy Balance Effects on Tumor Development: Alterations in Growth Factor and Energy Sensing Pathways
Mechanisms Associated with Dietary Energy Balance Effects on Tumor Development: Alterations in Growth Factor and Energy Sensing Pathways John DiGiovanni, Ph.D. Professor and Coulter R. Sublett Endowed
More informationSunflower vs Canola oil modulation of metabolic traits and tumor development in the South African rat dietary model of Breast Cancer.
Sunflower vs Canola oil modulation of metabolic traits and tumor development in the South African rat dietary model of Breast Cancer. Dr Annadie Krygsman and Dr Anneke Brand Background After cervical cancer,
More informationMechanisms of hormone drug resistance
Mechanisms of hormone drug resistance Ljiljana Stamatović Institute for Oncology and Radiology of Serbia Tenth UMOS Conference, Belgrade, 16-17 th May 2015. Hormone receptor-positive breast cancer (HR+
More informationDOWNLOAD PDF ADIPOSE TISSUE AND ADIPOKINES IN HEALTH AND DISEASE (NUTRITION AND HEALTH)
Chapter 1 : Adiposity, Adipokines, and Adiposopathy - Sick Fat Explained Adipose Tissue and Adipokines in Health and Disease, Second Edition is a useful resource for physicians interested in adipose tissue
More informationMikhail G. Kolonin Editor. Adipose Tissue and Cancer
Mikhail G. Kolonin Editor Adipose Tissue and Cancer Adipose Tissue and Cancer Mikhail G. Kolonin Editor Adipose Tissue and Cancer Editor Mikhail G. Kolonin Institute of Molecular Medicine Center for Stem
More informationOutline of the presentation
Outline of the presentation Breast cancer subtypes and classification Clinical need in estrogen-positive (ER+) metastatic breast cancer (mbc) Sulforaphane and SFX-01: the preclinical evidence STEM Phase
More informationThe Potential of Omega-3 Fatty Acid Supplements to Improve Outcomes in Obese Breast Cancer Patients Linda degraffenried, PhD Associate Professor
The Potential of Omega-3 Fatty Acid Supplements to Improve Outcomes in Obese Breast Cancer Patients Linda degraffenried, PhD Associate Professor Department of Nutritional Sciences University of Texas at
More informationGenome of Hepatitis B Virus. VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department
Genome of Hepatitis B Virus VIRAL ONCOGENE Dr. Yahwardiah Siregar, PhD Dr. Sry Suryani Widjaja, Mkes Biochemistry Department Proto Oncogen and Oncogen Oncogen Proteins that possess the ability to cause
More information* Author to whom correspondence should be addressed; Tel.: ; Fax:
Int. J. Mol. Sci. 2014, 15, 6184-6223; doi:10.3390/ijms15046184 Review OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Obesity and Its Metabolic Complications:
More informationUNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL. PhD THESIS
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL PhD THESIS THE IMPORTANCE OF TUMOR ANGIOGENESIS IN CEREBRAL TUMOR DIAGNOSIS AND THERAPY ABSTRACT PhD COORDINATOR: Prof. univ. dr. DRICU Anica PhD
More informationBiochimica et Biophysica Acta
Biochimica et Biophysica Acta 1807 (2011) 664 678 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbabio Review Role of obesity-associated
More informationTherapeutic strategy to reduce Glucagon secretion
Clinical focus on glucagon: α-cell as a companion of β-cell Therapeutic strategy to reduce Glucagon secretion Sunghwan Suh Dong-A University Conflict of interest disclosure None Committee of Scientific
More informationEndocrine Disrupters as Obesogens
Endocrine Disrupters as Obesogens Is the environment making us fat? Bruce Blumberg, Ph.D. Department of Developmental and Cell Biology Department of Pharmaceutical Sciences Developmental Biology Center
More informationEffects of growth hormone secretagogue receptor agonist and antagonist in nonobese type 2 diabetic MKR mice
Effects of growth hormone secretagogue receptor agonist and antagonist in nonobese type 2 diabetic MKR mice Rasha Mosa (MBCHC, M.D, PhD candidate) School of Biomedical Sciences University of Queensland
More informationContents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ
Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5
More informationNovel Strategies in Systemic Therapies: Overcoming Endocrine Therapy Resistance
Novel Strategies in Systemic Therapies: Overcoming Endocrine Therapy Resistance Richard S. Finn, MD Division of Hematology/ Oncology Director, Translational Oncology Laboratory Geffen School of Medicine
More informationNegative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α
Negative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α Mahnaz Janghorban, PhD Dr. Rosalie Sears lab 2/8/2015 Zanjan University Content 1. Background (keywords: c-myc, PP2A,
More informationA particular set of insults induces apoptosis (part 1), which, if inhibited, can switch to autophagy. At least in some cellular settings, autophagy se
A particular set of insults induces apoptosis (part 1), which, if inhibited, can switch to autophagy. At least in some cellular settings, autophagy serves as a defence mechanism that prevents or retards
More informationNo cases of precocious puberty were reported during clinical trials of risperidone in, cases of precocious puberty have been
levels than adults. The growth hormone elevations reported for the 12 patients with growth hormone excess were modest and well below levels reported in children with gigantism. 7,8 None of the patients
More informationIn The Name Of God. In The Name Of. EMRI Modeling Group
In The Name Of God In The Name Of God EMRI Modeling Group Cells work together in functionally related groups called tissues Types of tissues: Epithelial lining and covering Connective support Muscle movement
More informationmirna Dr. S Hosseini-Asl
mirna Dr. S Hosseini-Asl 1 2 MicroRNAs (mirnas) are small noncoding RNAs which enhance the cleavage or translational repression of specific mrna with recognition site(s) in the 3 - untranslated region
More informationMetabolic Syndrome and HCC. Jacob George
Metabolic Syndrome and HCC Jacob George MetS and risk of HCC and ICC All with HCC and ICC between 1993 and 2005 identified in the Surveillance, Epidemiology, and End Results (SEER)-Medicare database. For
More informationBCHM3972 Human Molecular Cell Biology (Advanced) 2013 Course University of Sydney
BCHM3972 Human Molecular Cell Biology (Advanced) 2013 Course University of Sydney Page 2: Immune Mechanisms & Molecular Biology of Host Defence (Prof Campbell) Page 45: Infection and Implications for Cell
More informationDIETARY FATTY ACID AND ADIPOSE TISSUE FUNCTION IN COLORECTAL CANCER. M. D Archivio - Istituto Superiore di Sanità
DIETARY FATTY ACID AND ADIPOSE TISSUE FUNCTION IN COLORECTAL CANCER M. D Archivio - Istituto Superiore di Sanità OBESITY dietary fatty acids Low grade chronic inflammation pstat3 PPARg CANCER adiponectin
More informationMechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, mirnas and Genetically Based Resistance
Int. J. Mol. Sci. 2013, 14, 108-145; doi:10.3390/ijms14010108 Review OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Mechanisms of Resistance to Endocrine
More informationMetabolism of cardiac muscle. Dr. Mamoun Ahram Cardiovascular system, 2013
Metabolism of cardiac muscle Dr. Mamoun Ahram Cardiovascular system, 2013 References This lecture Mark s Basic Medical Biochemistry, 4 th ed., p. 890-891 Hand-out Why is this topic important? Heart failure
More informationMultimedia Appendix 6 Educational Materials Table of Contents. Intervention Educational Materials Audio Script (version 1)
Multimedia Appendix 6 Educational Materials Table of Contents Intervention Educational Materials... 1 Audio Script (version 1)... 1 Text (version 1)... 5 Slides (version 1)... 17 Audio Script (version
More informationMETABOLIC SYNDROME AND HCV: FROM HCV
METABOLIC SYNDROME AND HCV: FROM THEORY TO PRACTICE HCV Steatosis Insulin resistance Arun J Sanyal M.D. Chairman, Div. of Gastroenterology, Hepatology and Nutrition Virginia Commonwealth University Richmond,
More informationLAPATINIB-Resistance to small Molecule ErbB2 Tyrosine Kinase Inhibitor (TKI)
LAPATINIB-Resistance to small Molecule ErbB2 Tyrosine Kinase Inhibitor (TKI) Prim Mr Sc Dr Suzana Vasović Institute for oncology and radiology of Serbia UMOS, X Conference, 16.05.2015 Belgrade How do we
More informationLeptin Intro/Signaling. ATeamP: Angelo, Anthony, Charlie, Gabby, Joseph
Leptin Intro/Signaling ATeamP: Angelo, Anthony, Charlie, Gabby, Joseph Overview Intro to Leptin Definition & Sources Physiology Bound vs. Free Receptors Signaling JAK/STAT MAPK PI3K ACC Experimental findings
More informationNeoplasia 2018 lecture 4. Dr Heyam Awad MD, FRCPath
Neoplasia 2018 lecture 4 Dr Heyam Awad MD, FRCPath ILOS To understand the concept of the hallmarks of cancer and that they are phenotypic changes needed in all cancer cells. To list the tumor enablers
More informationThe Open Access Institutional Repository at Robert Gordon University
OpenAIR@RGU The Open Access Institutional Repository at Robert Gordon University http://openair.rgu.ac.uk This is an author produced version of a paper published in Oncology Letters (ISSN 1792-1074, eissn
More informationDEVELOPMENTAL ORIGINS OF DIABETES AND CARDIOVASCULAR DISEASE. Goals
DEVELOPMENTAL ORIGINS OF DIABETES AND CARDIOVASCULAR DISEASE Goals Evolutionary paradox of obesity/diabetes Thrifty gene hypothesis Thrifty phenotype hypothesis Effects of small for gestational age (SGA)
More informationGrowth and Differentiation Phosphorylation Sampler Kit
Growth and Differentiation Phosphorylation Sampler Kit E 0 5 1 0 1 4 Kits Includes Cat. Quantity Application Reactivity Source Akt (Phospho-Ser473) E011054-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit
More informationDevelopment of important genes during breast carcinogenesis
Nagoya Med. J., 107 Development of important genes during breast carcinogenesis AYA NAIKI-ITO Department of experimental pathology and tumor biology Nagoya City University Graduate School of Medical Sciences
More informationRegulation of Lipid Homeostasis: Lipid Droplets
Regulation of Lipid Homeostasis: Lipid Droplets Bernd Helms Article Brand Recter Hendrik Mertens 1 The Basics I: FAs The Basics II: FA Activation 2 Basics III: TG-FA Interplay. Why? Adipocytes 3 Foam cells
More informationGenetics and Cancer Ch 20
Genetics and Cancer Ch 20 Cancer is genetic Hereditary cancers Predisposition genes Ex. some forms of colon cancer Sporadic cancers ~90% of cancers Descendants of cancerous cells all cancerous (clonal)
More informationInsulin/IGF1-IRS-PI-3 kinase-mtor signaling pathway
Insulin/IGF1-IRS-PI-3 kinase-mtor signaling pathway Nutrients RAPAMYCIN (FKBP12) mtor/rictor complex phosphorylates Akt at the S473 activating site in a Rheb-independent fashion TSC1 or TSC2-null MEFs
More informationSignaling. Dr. Sujata Persad Katz Group Centre for Pharmacy & Health research
Signaling Dr. Sujata Persad 3-020 Katz Group Centre for Pharmacy & Health research E-mail:sujata.persad@ualberta.ca 1 Growth Factor Receptors and Other Signaling Pathways What we will cover today: How
More informationJie Tian,, Claudio J. Conti, Robin Fuchs-Young. Find the latest version: J Clin Invest. 2012;122(1):
Developmental stage determines estrogen receptor alpha expression and non-genomic mechanisms that control IGF-1 signaling and mammary proliferation in mice Jie Tian,, Claudio J. Conti, Robin Fuchs-Young
More informationMetabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine
Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Setting the scene GB, 43 yo AA man followed for hypothyroidism returns on LT4 125 mcg/d and has a TSH=1.1
More informationA Study of Prolactin Secretion in Locally Limited and Metastatic Triple Negative Breast Cancer Patients
Human Journals Research Article May 2018 Vol.:9, Issue:3 All rights are reserved by Messina G et al. A Study of Prolactin Secretion in Locally Limited and Metastatic Triple Negative Breast Cancer Patients
More informationTHE ENDOCANNABINOID SYSTEM IN ADIPOSE TISSUE. Key Points
December 2008 (Vol. 1, Issue 3, pages 31-35) THE ENDOCANNABINOID SYSTEM IN ADIPOSE TISSUE By Uberto Pagotto, MD, PhD Endocrinology Unit and Center of Applied Biomedical Research (C.R.B.A.), Department
More informationThe g c Family of Cytokines Prof. Warren J. Leonard M.D.
The Family of Cytokines Chief, Laboratory of Molecular Immunology Director, Immunology Center National Heart, Lung, and Blood Institute National Institutes of Health Department of Health and Human Services
More informationExosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study
GBCC 2017: ABS-0017 Exosomal Del 1 as a potent diagnostic marker for breast cancer : A prospective cohort study Soo Jung Lee 1, Jeeyeon Lee 2, Jin Hyang Jung 2, Ho Yong Park 2, Chan Hyeong Lee 3, Pyong
More informationBreast Cancer: the interplay of biology, drugs, radiation. Prof. L. Livi Università degli Studi di Firenze. Brescia, October 3rd 4th, 2013
Breast Cancer: the interplay of biology, drugs, radiation Prof. L. Livi Università degli Studi di Firenze Brescia, October 3rd 4th, 2013 BACKGROUND (1) The complex interactions between tumor-specific signaling
More informationHunk is required for HER2/neu-induced mammary tumorigenesis
Research article Hunk is required for HER2/neu-induced mammary tumorigenesis Elizabeth S. Yeh, 1 Thomas W. Yang, 1 Jason J. Jung, 1 Heather P. Gardner, 1 Robert D. Cardiff, 2 and Lewis A. Chodosh 1 1 Department
More informationNitin Telang1, Guo Li2, Meena Katdare3,4 Daniel w. Sepkovic5,
Preventive Efficacy of the Chinese Nutritional Herb Epimedium grandiflorum in a Preclinical Cell Culture Model for Luminal A Molecular Subtype of Breast Cancer Nitin Telang1, Guo Li2, Meena Katdare3,4
More informationObesity in the pathogenesis of chronic disease
Portoroz October 16th 2013 Obesity in the pathogenesis of chronic disease Rocco Barazzoni University of Trieste Department of Medical, Surgical and Health Sciences Obesity Trends* Among U.S. Adults BRFSS,
More informationApoptosis Oncogenes. Srbová Martina
Apoptosis Oncogenes Srbová Martina Cell Cycle Control point Cyclin B Cdk1 Cyclin D Cdk4 Cdk6 Cyclin A Cdk2 Cyclin E Cdk2 Cyclin-dependent kinase (Cdk) have to bind a cyclin to become active Regulation
More informationAward Number: W81XWH TITLE: Dietary Fish Oil in Reducing Bone Metastasis of Breast Cancer
AD Award Number: W81XWH-04-1-0693 TITLE: Dietary Fish Oil in Reducing Bone Metastasis of Breast Cancer PRINCIPAL INVESTIGATOR: Nandini Ghosh-Choudhury, Ph.D. CONTRACTING ORGANIZATION: University of Texas
More informationNutritional and metabolic mechanisms. in the ovarian follicle
Nutritional and metabolic mechanisms in the ovarian follicle Joëlle Dupont Team Leader : «Interaction Metabolism and Reproduction» Unit of Physiology of Reproduction and Behaviors UMR 6175 INRA/CNRS/Université
More informationSupplementary Figure 1. IHC and proliferation analysis of pten-deficient mammary tumors
Wang et al LEGENDS TO SUPPLEMENTARY INFORMATION Supplementary Figure 1. IHC and proliferation analysis of pten-deficient mammary tumors A. Induced expression of estrogen receptor α (ERα) in AME vs PDA
More informationCHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION. Androgen deprivation therapy is the most used treatment of de novo or recurrent
CHAPTER VII CONCLUDING REMARKS AND FUTURE DIRECTION Stathmin in Prostate Cancer Development and Progression Androgen deprivation therapy is the most used treatment of de novo or recurrent metastatic PCa.
More informationNexus BioPharma, Inc. Opportunity Overview
Nexus BioPharma, Inc Opportunity Overview Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Securities Act of 1933, as amended, the Securities Exchange
More informationDeregulation of signal transduction and cell cycle in Cancer
Deregulation of signal transduction and cell cycle in Cancer Tuangporn Suthiphongchai, Ph.D. Department of Biochemistry Faculty of Science, Mahidol University Email: tuangporn.sut@mahidol.ac.th Room Pr324
More informationDefects in glucose utilization & GLP-1
Defects in glucose utilization & GLP-1 Song, Dae-Kyu Department of Physiology & Chronic Disease Research Center Keimyung University School of Medicine 2800 dalgubeol-daero, Dalseo-gu, Daegu, 704-701, Korea
More informationStatistical analysis the development of breast cancer; influencing factors
Statistical analysis the development of breast cancer; influencing factors Iuliana PANTELIMON* Abstract: The incidence of breast cancer in Romania is about 66.2/100,000 and the mortality around 22.1/100,000.
More informationDevelopment of a Metabolic Syndrome Mouse Model of Breast Cancer ANISHAH MANDANI ID#
Development of a Metabolic Syndrome Mouse Model of Breast Cancer ANISHAH MANDANI ID# 2223777 Thesis submitted for Bachelor of Biomedical Science with Honours 2015 University of Otago, Christchurch Abstract
More informationBREAST CANCER. Dawn Hershman, MD MS. Medicine and Epidemiology Co-Director, Breast Program HICCC Columbia University Medical Center.
BREAST CANCER Dawn Hershman, MD MS Florence Irving Assistant Professor of Medicine and Epidemiology Co-Director, Breast Program HICCC Columbia University Medical Center Background Breast cancer is the
More informationEnhancement of C2C12 myoblast proliferation and differentiation by diarylheptanoid form Curcuma comosa Roxb.
Enhancement of C2C12 myoblast proliferation and differentiation by diarylheptanoid form Curcuma comosa Roxb. Curcuma comosa Roxb. Mr. Chittipong Tipbunjong Mahidol University Bangkok, Thailand Muscle regeneration
More informationImplications of mitochondrial skeletal muscle metabolism on diabetes and obesity before and after weight loss
GG2 Implications of mitochondrial skeletal muscle metabolism on diabetes and obesity before and after weight loss Dr Giacomo Gastaldi CHRU Montpellier Folie 1 GG2 19.10.2009 GG_PC; 12.10.2009 Plan Introduction
More informationInterrogating mtor Inhibition in Patients with HRPC
Interrogating mtor Inhibition in Patients with HRPC Daniel George, John Madden, Andrew Armstrong, Mark Dewhirst, Nancy Major, and Phillip Febbo Divisions of Medical Oncology, Urology, Pathology, Radiology,
More informationConcise Reference. HER2 Testing in Breast Cancer. Mary Falzon, Angelica Fasolo, Michael Gandy, Luca Gianni & Stefania Zambelli
Concise Reference Testing in Breast Cancer Mary Falzon, Angelica Fasolo, Michael Gandy, Luca Gianni & Stefania Zambelli Extracted from Handbook of -Targeted Agents in Breast Cancer ublished by Springer
More informationPathogenesis of Diabetes Mellitus
Pathogenesis of Diabetes Mellitus Young-Bum Kim, Ph.D. Associate Professor of Medicine Harvard Medical School Definition of Diabetes Mellitus a group of metabolic diseases characterized by hyperglycemia
More informationJae Young So ALL RIGHTS RESERVED
2013 Jae Young So ALL RIGHTS RESERVED Suppression of Mammary Tumorigenesis by a Gemini Vitamin D Analog and a Synthetic Triterpenoid By JAE YOUNG SO A Dissertation submitted to the Graduate School-New
More informationThe PI3K/AKT axis. Dr. Lucio Crinò Medical Oncology Division Azienda Ospedaliera-Perugia. Introduction
The PI3K/AKT axis Dr. Lucio Crinò Medical Oncology Division Azienda Ospedaliera-Perugia Introduction Phosphoinositide 3-kinase (PI3K) pathway are a family of lipid kinases discovered in 1980s. They have
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationEstrogen. Cysteine Prevents oxidation of estrogen into a dangerous form that causes breast cancer. 29,30,31
Cysteine Prevents oxidation of estrogen into a dangerous form that causes breast cancer. 29,30,31 Estrogen lowers risk of zinc de ciency; dependent proteins metabolize estrogen. 26,27,28 Magnesium Cofactor
More informationHypothalamic & Pituitary Hormones
1 Hypothalamic & Pituitary Hormones Pharmacologic Applications: Drugs that mimic or block the effects of hypothalamic or pituitary hormones have the following applications: 1. Replacement therapy for hormone
More informationMolecular understanding of tamoxifen resistance in breast cancer. Renée de Leeuw
Molecular understanding of tamoxifen resistance in breast cancer Renée de Leeuw Omslag ontworpen door: Theophile Suijkerbuijk (www.theophile.nl) Molecular understanding of tamoxifen resistance in breast
More informationHypothalamic inflammation: a double-edged sword to nutritional diseases
Ann. N.Y. Acad. Sci. ISSN 0077-8923 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES Issue: The Year in Diabetes and Obesity Hypothalamic inflammation: a double-edged sword to nutritional diseases Dongsheng
More informationBCH Graduate Survey of Biochemistry
BCH 5045 Graduate Survey of Biochemistry Instructor: Charles Guy Producer: Ron Thomas Director: Marsha Durosier Lecture 44 Slide sets available at: http://hort.ifas.ufl.edu/teach/guyweb/bch5045/index.html
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationStress & The Neuroprotective Factors of Exercise. Week 9: Thursday, November 29 Sonia Romo
Stress & The Neuroprotective Factors of Exercise Week 9: Thursday, November 29 Sonia Romo Today s Agenda Old Brain in a New Society Stress and the Immune System Stress and CVD Stress and Metabolic Syndrome
More informationTreating patients affordably: personalized medicine in India
economic Treating patients affordably: personalized medicine in India biologic B Moni Abraham Kuriakose MB ChB, MD, FDSRCS, FFDRCS, FRCS Ed., FRCS, Dip AB Professor and Director, Department of Surgical
More information10/15/2012. Inflammatory Breast Cancer vs. LABC: Different Biology yet Subtypes Exist
Triple-Negative Breast Cancer: Optimizing Treatment for Locally Advanced Breast Cancer Beth Overmoyer MD Director, Inflammatory Breast Cancer Program Dana Farber Cancer Institute Overview Inflammatory
More information